{"id":"onabotulinumtoxina-injectable-product","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Headache"},{"rate":"5-10","effect":"Neck pain"},{"rate":"5-10","effect":"Injection site pain"},{"rate":"5-15","effect":"Muscle weakness"},{"rate":"1-5","effect":"Eyelid ptosis"},{"rate":"1-5","effect":"Dry mouth"},{"rate":"1-3","effect":"Flu-like symptoms"}]},"_chembl":{"chemblId":"CHEMBL1201574","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug is a botulinum toxin serotype A that irreversibly cleaves SNAP-25, a protein essential for acetylcholine vesicle fusion and release. This prevents neuromuscular transmission, resulting in localized muscle weakness or paralysis that typically lasts 3-4 months. The effect is reversible as the body gradually regenerates new nerve terminals.","oneSentence":"OnabotulinumtoxinA blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:20.413Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cervical dystonia"},{"name":"Blepharospasm"},{"name":"Strabismus"},{"name":"Chronic migraine"},{"name":"Severe primary axillary hyperhidrosis"},{"name":"Upper limb spasticity"},{"name":"Urinary incontinence due to neurogenic detrusor overactivity"}]},"trialDetails":[{"nctId":"NCT06783621","phase":"PHASE4","title":"A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products","status":"COMPLETED","sponsor":"AbbVie","startDate":"2025-01-16","conditions":"Facial Contouring","enrollment":130},{"nctId":"NCT07478822","phase":"PHASE3","title":"A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity","status":"RECRUITING","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2026-03-20","conditions":"Upper Limb Spasticity","enrollment":300},{"nctId":"NCT07388927","phase":"PHASE4","title":"A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A","status":"NOT_YET_RECRUITING","sponsor":"DKSH Management (Thailand) Limited","startDate":"2026-02","conditions":"Ecchymosis After Periorbital Rejuvenation With Botulinum Toxin Type A, Crow's Feet Lines, Lateral Canthal Lines, LCL","enrollment":48},{"nctId":"NCT07385742","phase":"NA","title":"Botulinum Toxin Versus Platelet Rich Fibrin for TMJ Internal Derangement","status":"COMPLETED","sponsor":"Suez Canal University","startDate":"2024-01-10","conditions":"Temporomandibular Joint Internal Derangement, Temporomandibular Joint Disorders, Temporomandibular Disorders (TMD)","enrollment":20},{"nctId":"NCT06585696","phase":"PHASE3","title":"A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)","status":"COMPLETED","sponsor":"Cutia Therapeutics（Wuxi）Co.,Ltd","startDate":"2024-06-11","conditions":"Glabellar Frown Lines","enrollment":554},{"nctId":"NCT07369453","phase":"NA","title":"Exercise to Improve Sleep and Quality of Life in Stroke Patients Receiving Botulinum Toxin Treatment","status":"COMPLETED","sponsor":"Bursa Yuksek Ihtisas Training and Research Hospital","startDate":"2021-09-15","conditions":"Hemiplegia and/or Hemiparesis Following Stroke","enrollment":56},{"nctId":"NCT07360483","phase":"NA","title":"Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-01-01","conditions":"Hypertrophic Scars","enrollment":48},{"nctId":"NCT06216886","phase":"PHASE4","title":"OnabotulinumtoxinA for Trigeminal Neuralgia","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-06-01","conditions":"Trigeminal Neuralgia","enrollment":20},{"nctId":"NCT06783114","phase":"PHASE2, PHASE3","title":"A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults","status":"RECRUITING","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2024-09-14","conditions":"Upper Limb Spasticity","enrollment":254},{"nctId":"NCT02414425","phase":"PHASE3","title":"Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-11-25","conditions":"Fecal Incontinence","enrollment":200},{"nctId":"NCT06070987","phase":"NA","title":"Exoskeleton Robotic Assisted Gait Training in Spastic Stroke Post Botulinum Toxin A Injection","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2023-08-01","conditions":"Spastic Gait, Spastic","enrollment":30},{"nctId":"NCT06899438","phase":"NA","title":"Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or Not","status":"COMPLETED","sponsor":"Bursa City Hospital","startDate":"2009-08-26","conditions":"Myofacial Pain Syndromes","enrollment":38},{"nctId":"NCT07270042","phase":"NA","title":"Evaluation the Efficacy of Zinc on Botulinum Toxin A Injection","status":"NOT_YET_RECRUITING","sponsor":"Tishreen University","startDate":"2025-12-01","conditions":"Hyperactive Masseter Muscle","enrollment":20},{"nctId":"NCT07268261","phase":"NA","title":"Combined Method of Surgical Treatment of Anal Fissure","status":"RECRUITING","sponsor":"State Scientific Centre of Coloproctology, Russian Federation","startDate":"2023-09-01","conditions":"Chronic Anal Fissure","enrollment":122},{"nctId":"NCT07242300","phase":"PHASE3","title":"Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .","status":"NOT_YET_RECRUITING","sponsor":"JHM BioPharma (Tonghua) Co. , Ltd.","startDate":"2026-01","conditions":"Upper Limb Spasticity (ULS)","enrollment":207},{"nctId":"NCT07220382","phase":"PHASE4","title":"Preoperative BOTOX® Injection for Large Ventral Hernia Repair","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-11-03","conditions":"Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral","enrollment":188},{"nctId":"NCT07236632","phase":"NA","title":"Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study","status":"NOT_YET_RECRUITING","sponsor":"Benha University","startDate":"2025-12-15","conditions":"Premature Ejaculation","enrollment":80},{"nctId":"NCT05330078","phase":"EARLY_PHASE1","title":"Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2022-03-11","conditions":"Keloid","enrollment":10},{"nctId":"NCT05123053","phase":"PHASE2","title":"Firdapse for Post-BOTOX Vocal Weakness","status":"COMPLETED","sponsor":"Augusta University","startDate":"2021-10-28","conditions":"Vocal Weakness(Post-BOTOX Injection)","enrollment":18},{"nctId":"NCT05806164","phase":"PHASE4","title":"Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2023-06-06","conditions":"Urgency Urinary Incontinence","enrollment":432},{"nctId":"NCT06796985","phase":"PHASE1","title":"Botox for Chronic Pelvic Pain","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-02-24","conditions":"Pelvic Floor Disorders","enrollment":30},{"nctId":"NCT07072806","phase":"PHASE4","title":"A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2022-06-14","conditions":"Forehead Rhytides","enrollment":20},{"nctId":"NCT05089357","phase":"","title":"Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2021-11-11","conditions":"Glabellar Lines","enrollment":250},{"nctId":"NCT04609020","phase":"PHASE4","title":"Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment","status":"COMPLETED","sponsor":"Allergan","startDate":"2023-02-15","conditions":"Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality","enrollment":64},{"nctId":"NCT07025642","phase":"NA","title":"Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes","status":"RECRUITING","sponsor":"Mackay Medical College","startDate":"2025-07-01","conditions":"Overactive Bladder (OAB)","enrollment":60},{"nctId":"NCT07013279","phase":"PHASE3","title":"Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines","status":"NOT_YET_RECRUITING","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2025-07-15","conditions":"Glabellar Lines","enrollment":324},{"nctId":"NCT04171531","phase":"PHASE3","title":"Sling vs Botox for Mixed Incontinence","status":"COMPLETED","sponsor":"NICHD Pelvic Floor Disorders Network","startDate":"2020-06-08","conditions":"Urinary Incontinence, Stress, Urinary Incontinence, Urge","enrollment":150},{"nctId":"NCT04075981","phase":"PHASE3","title":"Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-30","conditions":"Cardiac Surgery","enrollment":220},{"nctId":"NCT05968885","phase":"PHASE4","title":"Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2021-10-01","conditions":"Urinary Bladder, Overactive, Urodynamics, Effect of Drug","enrollment":300},{"nctId":"NCT06953271","phase":"PHASE4","title":"Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection","status":"NOT_YET_RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-05-15","conditions":"Overactive Bladder (OAB), Urinary Tract Infection (Diagnosis)","enrollment":164},{"nctId":"NCT02677805","phase":"PHASE3","title":"Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2016-03-30","conditions":"Glabellar Frown Lines","enrollment":251},{"nctId":"NCT04763265","phase":"PHASE2","title":"Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2020-06-24","conditions":"Frown Lines","enrollment":208},{"nctId":"NCT06778421","phase":"PHASE1","title":"Impact of OnabotulinumtoxinA (BOTOX®) on Stress","status":"RECRUITING","sponsor":"Center for Advanced Facial Plastic Surgery","startDate":"2025-01-20","conditions":"Stress (Psychology), Stress, Healthy Adult Female Participants","enrollment":20},{"nctId":"NCT06793683","phase":"EARLY_PHASE1","title":"Early BOTOX After Spinal Cord Injury","status":"ENROLLING_BY_INVITATION","sponsor":"University of Washington","startDate":"2024-07-27","conditions":"Spinal Cord Injuries","enrollment":10},{"nctId":"NCT05167864","phase":"NA","title":"Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2022-03-04","conditions":"Cosmetic Techniques","enrollment":143},{"nctId":"NCT04755595","phase":"PHASE2","title":"Combination Facial Aesthetic Treatment in Millennials","status":"COMPLETED","sponsor":"State University of New York - Downstate Medical Center","startDate":"2021-03-09","conditions":"Dermatological Non-Disease","enrollment":20},{"nctId":"NCT06729840","phase":"PHASE3","title":"Intralesional Treatment of Keloids","status":"RECRUITING","sponsor":"Sohag University","startDate":"2024-12-01","conditions":"Scar, Hypertrophic","enrollment":45},{"nctId":"NCT04630873","phase":"PHASE1","title":"Low or High Botox Dilution for the Hemiplegic Gait?","status":"RECRUITING","sponsor":"University of Ioannina","startDate":"2020-11-20","conditions":"Post Stroke Spastic Hemiplegia","enrollment":20},{"nctId":"NCT05072821","phase":"PHASE4","title":"Botulinum Toxin Type a Injection to Prevent Keloid Recurrence","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-10-13","conditions":"Scar Keloid","enrollment":28},{"nctId":"NCT05698979","phase":"PHASE3","title":"Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-01-01","conditions":"Buerger Disease, Raynaud Syndrome","enrollment":8},{"nctId":"NCT06583486","phase":"PHASE3","title":"A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2024-03-19","conditions":"Moderate to Severe Glabellar Lines","enrollment":488},{"nctId":"NCT01177358","phase":"PHASE2","title":"Botox in the Healing of Surgical Wounds of the Neck","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2010-05-31","conditions":"Scar","enrollment":40},{"nctId":"NCT06562023","phase":"NA","title":"Botulinum Toxin and Mesotherapy on Enhancement of Facial Scarring","status":"COMPLETED","sponsor":"Hams Hamed Abdelrahman","startDate":"2022-11-19","conditions":"Facial Scars","enrollment":33},{"nctId":"NCT06499688","phase":"PHASE3","title":"A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2023-12-28","conditions":"Moderate to Severe Glabellar Lines","enrollment":529},{"nctId":"NCT06203470","phase":"PHASE4","title":"Botox Versus Tacrolimus in Psoriasis Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-06","conditions":"Psoriasis Vulgaris","enrollment":60},{"nctId":"NCT05284019","phase":"PHASE4","title":"Real World Effectiveness of Eptinezumab in Participants With Migraine","status":"TERMINATED","sponsor":"H. Lundbeck A/S","startDate":"2022-03-04","conditions":"Migraine","enrollment":32},{"nctId":"NCT04754737","phase":"NA","title":"Antibiotic Usage Prior to OnabotulinumtoxinA Injection","status":"RECRUITING","sponsor":"Benaroya Research Institute","startDate":"2021-03-23","conditions":"Antibiotic Stewardship, Overactive Bladder, Onabotulinumtoxin A","enrollment":200},{"nctId":"NCT06213662","phase":"NA","title":"Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Achalasia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2022-11-01","conditions":"Cricopharyngeal Achalasia, Dysphagia","enrollment":20},{"nctId":"NCT06196606","phase":"NA","title":"Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2022-11-11","conditions":"Brain Stem Infarctions, Dysphagia, Oropharyngeal, Dysphagia, Esophageal","enrollment":20},{"nctId":"NCT05485207","phase":"EARLY_PHASE1","title":"Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2022-04-04","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":5},{"nctId":"NCT04124939","phase":"PHASE4","title":"Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-11-10","conditions":"Overactive Bladder","enrollment":41},{"nctId":"NCT06354127","phase":"PHASE3","title":"DWP450 for Treating Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2020-08-12","conditions":"Moderate to Severe Glabellar Lines","enrollment":473},{"nctId":"NCT06328556","phase":"NA","title":"Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Copka Sonpashan","startDate":"2024-03","conditions":"Cricopharyngeal Achalasia","enrollment":30},{"nctId":"NCT04502264","phase":"PHASE2","title":"Effects of EMG-driven Robot-assisted Therapy for the Distal Upper Limb Motor Function in the Chronic Stroke Patients With Botox Injections","status":"COMPLETED","sponsor":"Cheng-Hsin General Hospital","startDate":"2020-01-09","conditions":"Chronic Stroke, Spasticity as Sequela of Stroke, Robotic Rehabilitation","enrollment":24},{"nctId":"NCT06282679","phase":"NA","title":"Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea","status":"UNKNOWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-04-01","conditions":"Rosacea, Botulinum Toxin","enrollment":30},{"nctId":"NCT06225024","phase":"NA","title":"Efficacy of Extracorporeal Shock Wave Therapy on Spasticity","status":"COMPLETED","sponsor":"Kayseri City Hospital","startDate":"2022-03-15","conditions":"Stroke, Spasticity, Muscle","enrollment":40},{"nctId":"NCT04383912","phase":"NA","title":"Onabotulinum Toxin A in Direct Brow Lift","status":"UNKNOWN","sponsor":"Nova Scotia Health Authority","startDate":"2020-11-18","conditions":"Direct Brow Lift, Scarring","enrollment":16},{"nctId":"NCT06230146","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-05-01","conditions":"Keloid","enrollment":45},{"nctId":"NCT06207955","phase":"NA","title":"I-PRF After Arthrocentesis Plus Botox Injection to Lateral Pterygoid Muscle in Treatment of Anterior Disc Displacement","status":"UNKNOWN","sponsor":"Fayoum University","startDate":"2024-02","conditions":"TMJ Disc Disorder, TMJ Pain","enrollment":39},{"nctId":"NCT05719285","phase":"PHASE4","title":"Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2022-12-06","conditions":"Overactive Bladder, Overactive Bladder Syndrome, Urge Incontinence","enrollment":100},{"nctId":"NCT03508921","phase":"PHASE4","title":"Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-07-01","conditions":"Overactive Bladder, Urinary Tract Infections","enrollment":22},{"nctId":"NCT03712449","phase":"PHASE4","title":"A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment","status":"COMPLETED","sponsor":"Allergan","startDate":"2019-01-22","conditions":"Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality","enrollment":59},{"nctId":"NCT04922983","phase":"PHASE2","title":"Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis","status":"UNKNOWN","sponsor":"Manhattan Physical Medicine and Rehabilitation, LLP","startDate":"2021-07-01","conditions":"Scoliosis Idiopathic, Scoliosis; Adolescence, Scoliosis; Lumbar Region","enrollment":42},{"nctId":"NCT06034288","phase":"PHASE2","title":"Xeomin vs Botox for Treatment of Overactive Bladder Syndrome","status":"UNKNOWN","sponsor":"Walter Reed National Military Medical Center","startDate":"2023-05-04","conditions":"Overactive Bladder Syndrome","enrollment":64},{"nctId":"NCT04401176","phase":"PHASE2","title":"Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome","status":"COMPLETED","sponsor":"Walter Reed National Military Medical Center","startDate":"2020-09-15","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":58},{"nctId":"NCT03821402","phase":"PHASE2","title":"Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-12-12","conditions":"Upper Limb Spasticity","enrollment":83},{"nctId":"NCT03825315","phase":"PHASE2","title":"DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-12-31","conditions":"Plantar Fasciitis","enrollment":155},{"nctId":"NCT04826900","phase":"NA","title":"Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-08-01","conditions":"Hemiplegia, Spastic, Spastic","enrollment":31},{"nctId":"NCT06013644","phase":"EARLY_PHASE1","title":"Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-03","conditions":"Myofascial Trigger Point Pain, Myofascial Pain Syndrome","enrollment":39},{"nctId":"NCT03453632","phase":"PHASE2, PHASE3","title":"Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex","status":"UNKNOWN","sponsor":"University Hospital, Toulouse","startDate":"2018-06-14","conditions":"Epidermolysis Bullosa Simplex","enrollment":25},{"nctId":"NCT03911102","phase":"PHASE2","title":"Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2019-03-11","conditions":"Lateral Canthal Lines","enrollment":63},{"nctId":"NCT04259086","phase":"PHASE2","title":"Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2019-12-06","conditions":"Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)","enrollment":48},{"nctId":"NCT05891314","phase":"NA","title":"The Effect of Botulinum Toxin Injection After Hemorrhoidectomy in Pain Control.","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-12-01","conditions":"Pain, Haemorriodectomy, Anal Sphincterotomy","enrollment":60},{"nctId":"NCT05617118","phase":"","title":"BTA vs Baclofen for Pelvic Myofascial Pain Syndrome","status":"UNKNOWN","sponsor":"Saint Petersburg State University, Russia","startDate":"2022-12-01","conditions":"Chronic Pain, Chronic Pelvic Pain Syndrome, Myofascial Pain Syndrome","enrollment":52},{"nctId":"NCT03555916","phase":"PHASE3","title":"Botulinum Toxin Injections for Oral Neuropathic Pain","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-04-04","conditions":"Trigeminal Neuropathy, Traumatic","enrollment":43},{"nctId":"NCT02678377","phase":"PHASE4","title":"The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2016-02","conditions":"Mixed Urinary Incontinence, Stress Urinary Incontinence, Urgency Incontinence","enrollment":100},{"nctId":"NCT03786770","phase":"PHASE2","title":"Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2019-01-24","conditions":"Frown Lines","enrollment":61},{"nctId":"NCT03891680","phase":"NA","title":"Intra Articular Botox Injection in Treatment of Osteoarthritis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-10-20","conditions":"Osteoarthritis Knees Both","enrollment":60},{"nctId":"NCT02097121","phase":"PHASE3","title":"OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)","status":"TERMINATED","sponsor":"Allergan","startDate":"2014-05-23","conditions":"Urinary Incontinence, Urinary Bladder, Overactive","enrollment":56},{"nctId":"NCT05651256","phase":"PHASE2, PHASE3","title":"Efficacy of Botulinum Toxin in Temporomandibular Disorders","status":"COMPLETED","sponsor":"University of Salamanca","startDate":"2021-03-01","conditions":"Temporomandibular Joint Disorder Bilateral","enrollment":20},{"nctId":"NCT03608397","phase":"PHASE3","title":"Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-06-20","conditions":"Cervical Dystonia","enrollment":301},{"nctId":"NCT05615987","phase":"PHASE4","title":"Comparison of Botulinum Toxin Injection Techniques in Spasticity","status":"UNKNOWN","sponsor":"Konya Beyhekim Training and Research Hospital","startDate":"2022-12-01","conditions":"Spastic Hemiplegia","enrollment":60},{"nctId":"NCT02353871","phase":"PHASE3","title":"Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Ipsen","startDate":"2015-01","conditions":"Moderate to Severe Glabellar Lines","enrollment":185},{"nctId":"NCT01313312","phase":"PHASE3","title":"Dysport® Adult Upper Limb Spasticity Extension Study","status":"COMPLETED","sponsor":"Ipsen","startDate":"2011-11","conditions":"Nervous System Disorders","enrollment":258},{"nctId":"NCT05517538","phase":"NA","title":"Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique","status":"COMPLETED","sponsor":"Mohamed Hayder Oleish Salih","startDate":"2021-08-09","conditions":"Glabellar Frown Lines, Rhytides, Wrinkle","enrollment":15},{"nctId":"NCT02718118","phase":"PHASE4","title":"Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-04","conditions":"Glabellar Lines, Wrinkles","enrollment":60},{"nctId":"NCT05463822","phase":"EARLY_PHASE1","title":"Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder","status":"COMPLETED","sponsor":"Stanford University","startDate":"2019-06-20","conditions":"Overactive Bladder, Bladder, Overactive, Urge Incontinence","enrollment":15},{"nctId":"NCT04270214","phase":"NA","title":"Conversion to Dysport in CD","status":"UNKNOWN","sponsor":"Western University, Canada","startDate":"2020-06-01","conditions":"Cervical Dystonia","enrollment":33},{"nctId":"NCT03469999","phase":"PHASE3","title":"Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy","status":"COMPLETED","sponsor":"Columbia University","startDate":"2018-12-12","conditions":"Cerebral Palsy","enrollment":12},{"nctId":"NCT05380154","phase":"PHASE3","title":"Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.","status":"COMPLETED","sponsor":"Hugel","startDate":"2017-05-09","conditions":"Glabellar Lines","enrollment":500},{"nctId":"NCT00474032","phase":"NA","title":"Using Botox to Treat Patients With Idiopathic Clubfoot","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2003-03","conditions":"Clubfoot","enrollment":2000},{"nctId":"NCT02173405","phase":"PHASE1","title":"Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2014-08-01","conditions":"Myofascial Pain Syndromes, Myofascial Trigger Point Pain, Trigger Point Pain, Myofascial","enrollment":10},{"nctId":"NCT05162300","phase":"PHASE4","title":"Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles","status":"COMPLETED","sponsor":"Vitality Institute Medical Products","startDate":"2021-12-08","conditions":"Photoaging, Wrinkle, Sun Damaged Skin","enrollment":30},{"nctId":"NCT05296759","phase":"PHASE4","title":"Botulinum Toxin Type A in Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2021-02-01","conditions":"Diabetic Neuropathies","enrollment":30},{"nctId":"NCT03617367","phase":"PHASE3","title":"Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-09-05","conditions":"Cervical Dystonia","enrollment":357},{"nctId":"NCT03855046","phase":"PHASE4","title":"Complex Treatment of a Chronic Anal Fissure","status":"RECRUITING","sponsor":"State Scientific Centre of Coloproctology, Russian Federation","startDate":"2019-09-01","conditions":"Fissure in Ano","enrollment":340},{"nctId":"NCT02546999","phase":"PHASE4","title":"Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2015-09","conditions":"Cerebral Palsy, Muscle Spasticity","enrollment":61},{"nctId":"NCT03289702","phase":"PHASE3","title":"CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)","status":"COMPLETED","sponsor":"Medy-Tox","startDate":"2017-11-13","conditions":"Muscle Spasticity","enrollment":220},{"nctId":"NCT04807920","phase":"PHASE4","title":"BOTOX® at the Time of Prolapse Surgery for OAB","status":"UNKNOWN","sponsor":"Walter Reed National Military Medical Center","startDate":"2021-09-23","conditions":"Urinary Bladder, Overactive, Pelvic Organ Prolapse","enrollment":138},{"nctId":"NCT03543150","phase":"","title":"BOTOX® Drug Use Investigation (Spasmodic Dysphonia)","status":"UNKNOWN","sponsor":"GlaxoSmithKline","startDate":"2018-07-20","conditions":"Dysphonia","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Botox"],"phase":"marketed","status":"active","brandName":"OnabotulinumtoxinA Injectable Product","genericName":"OnabotulinumtoxinA Injectable Product","companyName":"University of Utah","companyId":"university-of-utah","modality":"Small molecule","firstApprovalDate":"","aiSummary":"OnabotulinumtoxinA blocks the release of acetylcholine at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis. Used for Cervical dystonia, Blepharospasm, Strabismus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}